Recursion Pharmaceuticals Inc. RXRX) on Wednesday reported a loss of $162.3 million in its third quarter. The Salt Lake City-based company said it had a loss of 36 cents per share.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback